Phreesia (NYSE:PHR) & Mitesco (OTCMKTS:MITI) Head-To-Head Contrast

Phreesia (NYSE:PHR) and Mitesco (OTCMKTS:MITI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability.

Profitability

This table compares Phreesia and Mitesco’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Phreesia	-5.35%	-8.75%	-6.12%
Mitesco	1,639.45%	N/A	-744.83%

Valuation and Earnings

This table compares Phreesia and Mitesco”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$419.81 million	3.25	-$58.53 million	($0.42)	-54.19
Mitesco	$40,000.00	105.63	-$2.51 million	N/A	N/A

Mitesco has lower revenue, but higher earnings than Phreesia.

Volatility & Risk

Phreesia has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, Mitesco has a beta of 2.17, indicating that its share price is 117% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Phreesia and Mitesco, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1	0	12	1	2.93
Mitesco	0	0	0	0	0.00

Phreesia currently has a consensus price target of $33.85, suggesting a potential upside of 48.71%. Given Phreesia’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Phreesia is more favorable than Mitesco.

Insider and Institutional Ownership

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 0.0% of Mitesco shares are owned by institutional investors. 5.5% of Phreesia shares are owned by company insiders. Comparatively, 4.9% of Mitesco shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Phreesia beats Mitesco on 8 of the 13 factors compared between the two stocks.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

About Mitesco

Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.